Healthcare Realty [HR] vs Ventas [VTR] Detailed Stock Comparison
Healthcare Realty
NYSE
Loading...
Ventas
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Healthcare Realty wins in 9 metrics, Ventas wins in 11 metrics, with 0 ties. Ventas appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Healthcare Realty | Ventas | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 39.90 | 194.30 | Healthcare Realty |
| Price-to-Book Ratio | 1.20 | 2.52 | Healthcare Realty |
| Debt-to-Equity Ratio | 102.02 | 108.90 | Healthcare Realty |
| PEG Ratio | 2.59 | 400.75 | Healthcare Realty |
| EV/EBITDA | 15.11 | 21.81 | Healthcare Realty |
| Profit Margin (TTM) | -32.94% | 2.82% | Ventas |
| Operating Margin (TTM) | 5.35% | 14.15% | Ventas |
| EBITDA Margin (TTM) | 5.35% | 14.15% | Ventas |
| Return on Equity | -7.52% | 1.38% | Ventas |
| Return on Assets (TTM) | 0.26% | 1.92% | Ventas |
| Free Cash Flow (TTM) | $252.64M | $725.78M | Ventas |
| Dividend Yield | 6.18% | 2.92% | Healthcare Realty |
| 1-Year Return | -3.86% | 16.01% | Ventas |
| Price-to-Sales Ratio (TTM) | 4.79 | 5.72 | Healthcare Realty |
| Enterprise Value | $10.81B | $42.06B | Ventas |
| EV/Revenue Ratio | 8.84 | 8.32 | Ventas |
| Gross Profit Margin (TTM) | 63.05% | 42.15% | Healthcare Realty |
| Revenue per Share (TTM) | $3 | $12 | Ventas |
| Earnings per Share (Diluted) | $-1.17 | $0.33 | Ventas |
| Beta (Stock Volatility) | 0.74 | 0.97 | Healthcare Realty |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Healthcare Realty vs Ventas Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Healthcare Realty | 1.99% | 3.74% | 4.38% | 17.83% | 2.67% | 2.73% |
| Ventas | -0.09% | 2.35% | 4.03% | 8.65% | 4.60% | 19.25% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Healthcare Realty | -3.86% | -33.18% | -40.65% | -27.75% | -28.55% | -55.23% |
| Ventas | 16.01% | 43.11% | 61.80% | 21.93% | 19.56% | 99.31% |
Performance & Financial Health Analysis: Healthcare Realty vs Ventas
| Metric | HR | VTR |
|---|---|---|
| Market Information | ||
| Market Cap | $5.86B | $28.94B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 3,479,350 | 2,946,590 |
| 90 Day Avg. Volume | 3,905,603 | 2,823,467 |
| Last Close | $16.92 | $69.12 |
| 52 Week Range | $14.09 - $18.90 | $56.68 - $71.36 |
| % from 52W High | -10.48% | -3.14% |
| All-Time High | $44.19 (Feb 05, 2007) | $96.05 (May 20, 2013) |
| % from All-Time High | -61.71% | -28.04% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.06% | 0.14% |
| Quarterly Earnings Growth | -0.06% | 0.13% |
| Financial Health | ||
| Profit Margin (TTM) | -0.33% | 0.03% |
| Operating Margin (TTM) | 0.05% | 0.14% |
| Return on Equity (TTM) | -0.08% | 0.01% |
| Debt to Equity (MRQ) | 102.02 | 108.90 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $13.70 | $25.43 |
| Cash per Share (MRQ) | $0.08 | $0.40 |
| Operating Cash Flow (TTM) | $468.32M | $1.38B |
| Levered Free Cash Flow (TTM) | $98.74M | $869.68M |
| Dividends | ||
| Last 12-Month Dividend Yield | 6.18% | 2.92% |
| Last 12-Month Dividend | $0.93 | $1.83 |
Valuation & Enterprise Metrics Analysis: Healthcare Realty vs Ventas
| Metric | HR | VTR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 39.90 | 194.30 |
| Forward P/E | -39.21 | 400.75 |
| PEG Ratio | 2.59 | 400.75 |
| Price to Sales (TTM) | 4.79 | 5.72 |
| Price to Book (MRQ) | 1.20 | 2.52 |
| Market Capitalization | ||
| Market Capitalization | $5.86B | $28.94B |
| Enterprise Value | $10.81B | $42.06B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.84 | 8.32 |
| Enterprise to EBITDA | 15.11 | 21.81 |
| Risk & Other Metrics | ||
| Beta | 0.74 | 0.97 |
| Book Value per Share (MRQ) | $13.70 | $25.43 |
Financial Statements Comparison: Healthcare Realty vs Ventas
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | HR | VTR |
|---|---|---|
| Revenue/Sales | $297.50M | $1.36B |
| Cost of Goods Sold | $109.92M | $785.71M |
| Gross Profit | $187.58M | $572.37M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $16.35M | $197.69M |
| EBITDA | $175.45M | $521.86M |
| Pre-Tax Income | $-160.14M | $37.80M |
| Income Tax | N/A | $-10.56M |
| Net Income (Profit) | $-160.14M | $48.36M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | HR | VTR |
|---|---|---|
| Cash & Equivalents | $25.72M | $897.85M |
| Total Current Assets | $32.36M | $1.35B |
| Total Current Liabilities | $239.28M | $1.30B |
| Long-Term Debt | $4.94B | $13.73B |
| Total Shareholders Equity | $5.15B | $10.83B |
| Retained Earnings | $329.44M | N/A |
| Property, Plant & Equipment | $259.76M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | HR | VTR |
|---|---|---|
| Operating Cash Flow | $99.90M | $352.04M |
| Capital Expenditures | $-69.13M | N/A |
| Free Cash Flow | $-21.34M | $203.39M |
| Debt Repayment | $-35.48M | $-88.55M |
| Common Stock Repurchase | $-215,000 | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | HR | VTR |
|---|---|---|
| Shares Short | 13.53M | 13.72M |
| Short Ratio | 3.60 | 4.13 |
| Short % of Float | 0.07% | 0.04% |
| Average Daily Volume (10 Day) | 3,479,350 | 2,946,590 |
| Average Daily Volume (90 Day) | 3,905,603 | 2,823,467 |
| Shares Outstanding | 350.53M | 437.08M |
| Float Shares | 328.62M | 448.90M |
| % Held by Insiders | 0.01% | 0.01% |
| % Held by Institutions | 1.08% | 1.00% |
Dividend Analysis & Yield Comparison: Healthcare Realty vs Ventas
| Metric | HR | VTR |
|---|---|---|
| Last 12-Month Dividend | $0.93 | $1.83 |
| Last 12-Month Dividend Yield | 6.18% | 2.92% |
| 3-Year Avg Annual Dividend | $1.09 | $1.66 |
| 3-Year Avg Dividend Yield | 1.54% | 0.91% |
| 3-Year Total Dividends | $3.26 | $4.98 |
| Ex-Dividend Date | Mar 03, 2025 | Mar 31, 2025 |